Aida Pharmaceuticals, Inc.
AIDA · OTC
12/31/2007 | 12/31/2006 | 12/31/2005 | 12/31/2004 | |
|---|---|---|---|---|
| Market Cap | $31 | $47 | $43 | $11 |
| - Cash | $8 | $6 | $3 | $0 |
| + Debt | $33 | $30 | $25 | $0 |
| Enterprise Value | $55 | $70 | $65 | $11 |
| Revenue | $29 | $30 | $25 | $16 |
| % Growth | -1.5% | 20.9% | 56.8% | – |
| Gross Profit | $15 | $16 | $16 | $11 |
| % Margin | 50.3% | 52.5% | 66% | 70.5% |
| EBITDA | $7 | $6 | $4 | $4 |
| % Margin | 25.1% | 20.3% | 15.5% | 23.2% |
| Net Income | $3 | $1 | $1 | $2 |
| % Margin | 9.4% | 4.9% | 6% | 10.5% |
| EPS Diluted | 0.1 | 0.06 | 0.06 | 0.07 |
| % Growth | 66.7% | 0% | -14.2% | – |
| Operating Cash Flow | $8 | $3 | $6 | – |
| Capital Expenditures | -$4 | -$3 | -$1 | – |
| Free Cash Flow | $5 | -$0 | $5 | – |